We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
Cap. Flow
+$1.34B
Cap. Flow %
13.16%
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Financials 15.64%
3 Healthcare 14.3%
4 Consumer Discretionary 12.01%
5 Industrials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWI icon
501
Armstrong World Industries
AWI
$7.03B
$2.51M 0.02%
26,751
-71,784
-73% -$6.86M
CVGI icon
502
Commercial Vehicle Group
CVGI
$154M
$2.51M 0.02%
395,689
+239,439
+153% +$1.7M
DVN icon
503
Devon Energy
DVN
$50B
$2.49M 0.02%
95,800
-578,086
-86% -$13M
RVI
504
DELISTED
Retail Value Inc. Common Shares
RVI
$2.49M 0.02%
736,354
+386,839
+111% +$1.3M
ACOR
505
DELISTED
Acorda Therapeutics
ACOR
$2.48M 0.02%
10,115
+1,881
+23% +$475K
OMER icon
506
Omeros
OMER
$816M
$2.48M 0.02%
175,669
+100,900
+135% +$1.48M
REG icon
507
Regency Centers
REG
$15.1B
$2.48M 0.02%
39,226
-8,824
-18% -$579K
IRBT
508
DELISTED
iRobot
IRBT
$2.47M 0.02%
+48,700
New +$2.45M
SIRI icon
509
SiriusXM
SIRI
$10.5B
$2.46M 0.02%
+34,463
New +$2.32M
ESPR
510
DELISTED
Esperion Therapeutics
ESPR
$2.46M 0.02%
41,247
+8,937
+28% +$402K
UBX
511
DELISTED
Unity Biotechnology
UBX
$2.43M 0.02%
+33,750
New +$2.38M
DFIN icon
512
Donnelley Financial Solutions
DFIN
$1.26B
$2.4M 0.02%
+229,682
New +$2.41M
BKD icon
513
Brookdale Senior Living
BKD
$3.71B
$2.4M 0.02%
330,607
+241,707
+272% +$1.8M
ENVA icon
514
Enova International
ENVA
$6.23B
$2.4M 0.02%
99,898
-24,932
-20% -$561K
BMRC icon
515
Bank of Marin Bancorp
BMRC
$496M
$2.39M 0.02%
53,110
-3,635
-6% -$161K
CNDT icon
516
Conduent
CNDT
$240M
$2.35M 0.02%
+378,754
New +$2.37M
PENG
517
Penguin Solutions Inc
PENG
$2.71B
$2.34M 0.02%
+123,300
New +$1.91M
TNAV
518
DELISTED
Telenav Inc.
TNAV
$2.31M 0.02%
474,797
+75,386
+19% +$367K
VIVO
519
DELISTED
Meridian Bioscience Inc
VIVO
$2.3M 0.02%
+235,526
New +$2.21M
AKBA icon
520
Akebia Therapeutics
AKBA
$341M
$2.29M 0.02%
+361,633
New +$1.72M
IBKR icon
521
Interactive Brokers
IBKR
$40.9B
$2.28M 0.02%
195,908
FHB icon
522
First Hawaiian
FHB
$3.38B
$2.24M 0.02%
77,748
+2,753
+4% +$77.4K
NSIT icon
523
Insight Enterprises
NSIT
$3.69B
$2.21M 0.02%
31,481
-141,741
-82% -$8.93M
BNFT
524
DELISTED
Benefitfocus, Inc.
BNFT
$2.21M 0.02%
+100,884
New +$2.28M
XHR
525
Xenia Hotels & Resorts
XHR
$2B
$2.19M 0.02%
101,292
+1,038
+1% +$21.9K

Similar funds

Jacobs Levy Equity Management's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
  • Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
  • Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
  • Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
  • Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
  • Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.